Respiratory Infections News

A quarter of adults with a refractory nontuberculous mycobacterial infection had culture conversion during a 48-week daily inhaled molgramostim treatment period, according to results published in Annals of the American Thoracic Society.

A dose of Pfizer’s respiratory syncytial virus vaccine was well tolerated and generated a strong immune response among adults aged 59 years or younger, the company announced in a press release.

Patients with tuberculosis who used tobacco faced a heightened risk for disease recurrence/relapse and death during treatment, according to a systematic review and meta-analysis published in CHEST.

The incidence of heart attack and stroke is lower among people who have been vaccinated against COVID-19 compared with before vaccination and people who have not received a vaccine, according to a study.

There are several methods and tools clinicians can utilize to improve vaccine confidence and boost immunization rates as the respiratory virus season approaches, according to an expert panel.

Routine childhood vaccinations prevented more than 1.1 million deaths among children born during the past 30 years in the United States, CDC researchers found.

Between initial presentation in the ED and hospital discharge, 56.7% of veterans experienced a change in their pneumonia diagnosis, according to results published in Annals of Internal Medicine.

WHO this week announced a project to speed development of a messenger RNA vaccine against highly pathogenic avian influenza in humans.

CMS included a new infectious disease consult add-on code as part of its proposed new fee schedule could help improve compensation for ID clinicians, according to the Infectious Diseases Society of America.

The Pan American Health Organization issued an epidemiological alert in July regarding a significant rise in pertussis cases in the Americas and across the globe, according to a press release.